Vista Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Vista Pharma on BSE

Search Inside the pdf :

Vista Pharmaceuticals Ltd.

29 Apr 2026

7.45

2.62%

Corp. Note

Vista Pharmaceuticals Ltd - 524711 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Vista Pharmaceuticals Ltd 2 CIN NO. L24239TG1991PLC012264 3 Report filed for FY 2025-2026 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2025-26, 2026-27 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2024-25, 2025-26 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Barka JainDesignation :-Company Secretary compliance Officer Name of the Chief Financial Officer :- Suneel pachipala Designation : -CFO Date: 29/04/2026

pdf

Vista Pharmaceuticals Ltd.

14 Apr 2026

7.45

2.62%

Company Update

Vista Pharmaceuticals Ltd - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance - certificate under Reg. 74(5) of SEBI (DP) Regulations 2018

pdf

Vista Pharmaceuticals Ltd.

27 Mar 2026

7.45

2.62%

SAST

Vista Pharmaceuticals Ltd - 524711 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Vista Pharmaceuticals Ltd.

13 Feb 2026

7.45

2.62%

Board Meeting

Vista Pharmaceuticals Ltd - 524711 - Board Meeting Outcome for Un Audited Financial Results For The …

BSE India

Un audited Financial Results for the quarter ended 31.12.2025

pdf

Vista Pharmaceuticals Ltd.

13 Feb 2026

7.45

2.62%

Result

Vista Pharmaceuticals Ltd - 524711 - Results For The Quarter Ended 31.12.2025

BSE India

Results for the quarter ended 31.12.2025

pdf

Vista Pharmaceuticals Ltd.

05 Feb 2026

7.45

2.62%

Company Update

Vista Pharmaceuticals Ltd - 524711 - Update on board meeting

BSE India

The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026 The Board Meeting to be held on 23/02/2026 has been revised to 13/02/2026

pdf

Vista Pharmaceuticals Ltd.

05 Feb 2026

7.45

2.62%

Board Meeting

Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for 1. Unaudited Financial Results For The …

BSE India

Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2026 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter and nine months ended 31.12.2025. 2. Limited Review Report quarter and nine months 31.12.2025. 3. Any other business with the permission of the Chair.

pdf